Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.101,37
0,34%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cyclo Therapeutics Inc (CYTH) Cyclo Therapeutics Inc (CYTH) Notizie

Cyclo Therapeutics Inc

CYTH
1,51
0,04 (2,72%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/3/202414:05BWCyclo Therapeutics Reports Full Year 2023 Financial Results..
14/3/202414:34BWCyclo Therapeutics Announces Issuance of U.S. Patent..
13/3/202422:04GLOBERafael Holdings Reports Second Quarter Fiscal 2024 Financial..
04/3/202422:33EDGAR2Form 8-K/A - Current report: [Amend]
15/2/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202415:15BWCyclo Therapeutics Announces Allowance of Patent Application..
22/1/202412:01EDGAR2Form 8-K - Current report
29/12/202303:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202303:48EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/12/202322:28EDGAR2Form 8-K - Current report
28/12/202302:25EDGAR2Form 8-K - Current report
27/12/202322:15BWCyclo Therapeutics, Inc. Completes Merger with Applied..
26/12/202322:15EDGAR2Form 8-K - Current report
18/12/202315:15BWCyclo Therapeutics Announces Positive Outcome from Type C..
18/12/202312:02EDGAR2Form 425 - Prospectuses and communications, business..
18/12/202312:01EDGAR2Form 8-K - Current report
14/12/202322:01GLOBERafael Holdings Reports First Quarter Fiscal 2024 Financial..
30/11/202322:30EDGAR2Form 425 - Prospectuses and communications, business..
30/11/202322:29EDGAR2Form 8-K - Current report
30/11/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/11/202314:05BWCyclo Therapeutics to Present at the 20th Annual..
20/11/202314:50EDGAR2Form S-4/A - Registration of securities, business..
15/11/202314:05BWCyclo Therapeutics Reports Third Quarter 2023 Financial..
14/11/202320:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:45EDGAR2Form S-4 - Registration of securities, business combinations
31/10/202321:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:01GLOBERafael Holdings Reports Fourth Quarter and Full Year Fiscal..
24/10/202322:43EDGAR2Form SC 13D/A - General statement of acquisition of..
23/10/202314:05BWCyclo Therapeutics Announces Early Exercise of Warrants by..
23/10/202312:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202312:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202312:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202312:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202312:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202320:19EDGAR2Form 8-K - Current report
05/10/202314:05BWCyclo Therapeutics to Present at 8th Annual Dawson James..
Apertura: 1,50 Min: 1,48 Max: 1,55
Chiusura: 1,47

La tua Cronologia

NASDAQ
CYTH
Cyclo Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network